Literature DB >> 3310663

Release of renin and angiotensin II into plasma and lymph during hyperchloremia.

C S Wilcox1, W S Peart.   

Abstract

Renal vascular resistance (RVR) was related to intrarenal release of renin (RR) and angiotensin II (ANG II) during increases in plasma osmolality (Posmol) or chloride (PCl). Intrarenal infusions of 1.232 M solutions given to in situ kidneys increased Posmol by 7-18%. Hypertonic dextrose (n = 8) reduced RVR (P less than 0.005) but increased RR into plasma (P less than 0.01) and increased lymph renin (LR) (P less than 0.05). The response to hypertonic Na acetate (n = 5) was similar, but hypertonic NaCl (n = 9) increased RVR (P less than 0.02) without changing RR. During infusion of arachidonic acid (AA), hypertonic NaCl increased RVR (P less than 0.02) but decreased RR into plasma and decreased LR (P less than 0.05). Overall group mean changes in RVR were inversely related to LR (r = -0.96; P less than 0.01). An increase in PCl of 12 +/- 1 mmol/l was induced in denervated kidneys by changing an intrarenal 0.616 M infusion of Na acetate to NaCl. Hyperchloremia increased RVR from 14 +/- 2 to 19 +/- 2 mmHg . ml-1 . min-1 . kg-1 (P less than 0.01), reduced GFR from 1.4 +/- 0.1 to 1.1 +/- 0.1 ml . min-1 . kg-1 (P less than 0.01), and reduced ANG II (pg/ml) in renal venous plasma (55 +/- 6 to 35 +/- 6; P less than 0.05) and lymph (366 +/- 111 to 209 +/- 53; P less than 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3310663     DOI: 10.1152/ajprenal.1987.253.4.F734

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  13 in total

Review 1.  "I don't get no respect": the role of chloride in acute kidney injury.

Authors:  Joshua L Rein; Steven G Coca
Journal:  Am J Physiol Renal Physiol       Date:  2018-12-12

2.  Review: Intrarenal angiotensin II levels in normal and hypertensive states.

Authors:  L Gabriel Navar; Kenneth D Mitchell; Lisa M Harrison-Bernard; Hiroyuki Kobori; Akira Nishiyama
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2001-03       Impact factor: 1.636

3.  Renal haemodynamics during hyperchloraemia in the anaesthetized dog: effects of captopril.

Authors:  C S Wilcox
Journal:  J Physiol       Date:  1988-12       Impact factor: 5.182

Review 4.  Evolving concepts on regulation and function of renin in distal nephron.

Authors:  Minolfa C Prieto; Alexis A Gonzalez; L Gabriel Navar
Journal:  Pflugers Arch       Date:  2012-09-19       Impact factor: 3.657

Review 5.  Regulation of renin secretion by renal juxtaglomerular cells.

Authors:  Ulla G Friis; Kirsten Madsen; Jane Stubbe; Pernille B L Hansen; Per Svenningsen; Peter Bie; Ole Skøtt; Boye L Jensen
Journal:  Pflugers Arch       Date:  2012-06-26       Impact factor: 3.657

Review 6.  Regulation of intrarenal angiotensin II in hypertension.

Authors:  L Gabriel Navar; Lisa M Harrison-Bernard; Akira Nishiyama; Hiroyuki Kobori
Journal:  Hypertension       Date:  2002-02       Impact factor: 10.190

Review 7.  Crystalloid fluid choice in the critically ill : Current knowledge and critical appraisal.

Authors:  Carmen A Pfortmueller; Barbara Kabon; Joerg C Schefold; Edith Fleischmann
Journal:  Wien Klin Wochenschr       Date:  2018-03-02       Impact factor: 1.704

Review 8.  [Hemodilution and infusion therapy for hypovolemic shock. Clinical physiological and pharmacological aspects].

Authors:  H A Adams
Journal:  Anaesthesist       Date:  2007-04       Impact factor: 1.041

Review 9.  A balanced view of balanced solutions.

Authors:  Bertrand Guidet; Neil Soni; Giorgio Della Rocca; Sibylle Kozek; Benoît Vallet; Djillali Annane; Mike James
Journal:  Crit Care       Date:  2010-10-21       Impact factor: 9.097

10.  Effects of tight versus non tight control of metabolic acidosis on early renal function after kidney transplantation.

Authors:  Farhad Etezadi; Pejman Pourfakhr; Mojtaba Mojtahedzade; Atabak Najafi; Reza Shariat Moharari; Kourosh Karimi Yarandi; Mohammad Reza Khajavi
Journal:  Daru       Date:  2012-09-10       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.